She suggested I start taking the GLP-1 Zepbound through weekly injections, along with incorporating a healthy diet and ...

Wegovy and Zepbound, the two leading weight-loss drugs, together sold less than $5 billion in 2023, according to ...

With GLP-1 shortage officially over, patients who relied on compounded copies have only bad options to choose from ...

There is a low incidence rate of suicide-related adverse events among adults with diabetes or obesity being treated with GLP-1 RAs.

People taking GLP-1 receptor agonists appeared to be at elevated risk of rejection episodes after lung transplantation, a ...

Glucagon-like peptide 1 receptor agonists appear to reduce the risk of age-related macular degeneration and primary open-angle glaucoma.

Different from type 1 and type 2, type 5 diabetes mostly affects children for genetic reasons. Since it is rare, it often ...

China These authors contributed equally to this work. Correspondence to: Dr. Xi Cao, Beijing Diabetes Institute, Department of Endocrinology, Beijing Tongren Hospital, Capital Medical University, No.

Taking the drug made one writer feel so sick she quit and focused on healthy habits instead of her body size. Turns out, 65% ...

Diabetic kidney disease is chronic kidney disease that occurs as a complication of diabetes. Learn about its signs and ...

Two common GLP-1 medications that are approved by the Food and Drug Administration (FDA) specifically for weight loss are ...

medullary thyroid cancer and acute kidney injury. Dr Naveed Asif, GP at The London General Practice, advises that patients taking GLP-1 drugs should with a lower dose and gradually titrate up to ...